@misc{indiciae2f5a0ab9f394,
  title = {Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated},
  author = {Torres-Flores, A. and Ontiveros-Padilla, L. A. and Madera-Sandoval, R. L. and Tepale-Segura, A. and Gajon-Martinez, J. and Rivera-Hernandez, T. and Ferat-Osorio, E. A. and Cerbulo-Vazquez, A. and Arriaga-Pizano, L. A. and Bonifaz, L. and Paz-De la Rosa, G. and Rojas-Martinez, O. and Suarez-Martinez, A. and Peralta-Sanchez, G. and Sarfati-Mizrahi, D. and Sun, W. and Chagoya-Cortes, H. E. and Palese, P. and Krammer, F. and Garcia-Sastre, A. and Lozano-Dubernard, B. and Lopez-Macias, C.},
  year = {2024},
  doi = {10.1101/2024.03.01.582987},
  url = {https://www.biorxiv.org/content/10.1101/2024.03.01.582987v1},
  note = {Source identifier: 10.1101/2024.03.01.582987}
}